Details for New Drug Application (NDA): 009127
✉ Email this page to a colleague
NDA 009127 describes CORTRIL, which is a drug marketed by Pfizer, Pfizer Global, and Pfipharmecs, and is included in four NDAs. Additional details are available on the CORTRIL profile page.
The generic ingredient in CORTRIL is hydrocortisone. There are sixty-seven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
The generic ingredient in CORTRIL is hydrocortisone. There are sixty-seven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 009127
| Tradename: | CORTRIL |
| Applicant: | Pfizer |
| Ingredient: | hydrocortisone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009127
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
